SCOPE-AD Agent for Cost-Aware Alzheimer's Disease Diagnosis
October 2, 2026
SCOPE-AD uses energy-based models to train a Qwen policy for sequential diagnostic decision-making in Alzheimer's care. The agent selects tests based on cost, patient burden, and ordinal belief updates to distinguish between CN, MCI, and AD cases.
HOW THIS AFFECTS YOU
●
researcherYou can study the application of energy-based distillation for sequential decision-making in medical contexts.
●
healthThis could optimize clinical workflows by balancing diagnostic accuracy with patient cost and burden.